PATENT CLAIM ANALYSIS

Application Number: 15941030
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "006700"]

Abstract:
The present invention provides a novel peptide compound having an activating action on GIP receptors and use of the peptide compound as a medicament. Specifically, a peptide containing a sequence represented by the formula (I) or a salt thereof and a medicament comprising the same are provided. P 1 -Tyr-A2-Glu-Gly-Thr-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A18-A19-A20-A21-A22-A23-A24-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-A37-A38-A39-A40-P 2    (I) wherein each symbol is as defined herein.

Claim (Index 19):
A medicament comprising the peptide according to  claim 1 , or a salt thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.36735
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16303975', '14780579', '14125061', '14800627', '14287514']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8271480514132753
- 35 USC 102 Novelty (BERT): 0.6755451737497139
- Combined Prediction Score: 0.8119877636469192
- Mean Citation Score: 634.65795
- Max Citation Score: 721.8596
- Similarity Product: 643.0394583450557

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test